Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis [Myocardial Infarction]

Conclusions— ST-segment–elevation myocardial infarction patients receiving pharmacoinvasive treatment, compared with PPCI, had shorter time to reperfusion, higher culprit-vessel patency, and similar 12-month clinical outcome.

http://circinterventions.ahajournals.org/cgi/content/short/9/9/e003508?rss=1

Source: Circulation: Cardiovascular Interventions - August 30, 2016 Category: Cardiology Authors: Sim, D. S., Jeong, M. H., Ahn, Y., Kim, Y. J., Chae, S. C., Hong, T. J., Seong, I. W., Chae, J. K., Kim, C. J., Cho, M. C., Rha, S.-W., Bae, J. H., Seung, K. B., Park, S. J., on behalf of the Korea Acute Myocardial Infarction Registry (KAMIR) Investigator Tags: Myocardial Infarction, Catheter-Based Coronary and Valvular Interventions Source Type: research